ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268965; 2) Community: the network communities that were significantly associated with the response to NSC 268965; 3) Molecule: the relationships between components within communities and NSC 268965; 4) MDR: the compounds that were significantly associated with the NSC 268965.

NSC Compound Enrichment Correlation
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0284045326811616 0.24526076
NSC 362454 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- 0.0284045326811616 -0.083027989
NSC 602613 Null 0.0284045326811616 0.087207239
NSC 623902 Null 0.0284045326811616 0.086052982
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.0284045326811616 0.064077287
NSC 651003 Null 0.0284045326811616 0.13986182
NSC 658140 Null 0.0284045326811616 0.34175821
NSC 677949 Quinoline-5,8-dione, 7-[(3-hydroxy-3-phenyl-2-propyl)amino]- 0.0284045326811616 0.18721205
NSC 681634 Camptothecin Derivative 0.0284045326811616 0.48735787
NSC 681644 Camptothecin Derivative 0.0284045326811616 0.62013445
Total:50  Current:26    [First] [Prev] [Next] [Last]